IRB Advisor – June 1, 2010
June 1, 2010
View Issues
-
Are gays and lesbians being unfairly excluded from your clinical trials?
A recent analysis of clinical trials showing that gays and lesbians have been excluded from certain types of studies is causing reverberations within the research community and beyond. -
Health care reform law: Follow the money
As sweeping as the 906-page health care reform bill is, it will have limited impact on human subjects research protection, experts say. -
Explain research, give kids greater role
Despite efforts by IRBs and investigators to improve pediatric assent, a survey of children with cancer who have been enrolled in clinical trials showed they often don't understand that what they're involved in is research and that they wanted more of a say in making the decision to participate. -
Building trust in the research partnership
Improving the participation of minority populations in research has been a holy grail for researchers and IRBs. -
EUA or eIND? Testing drugs in an emergency
With the end of the 2009-2010 flu season, it's easy to get complacent about the threat of pandemic flu. After all, the much-feared H1N1 virus appears to be on the wane in the United States, and total deaths here didn't reach some dire predictions made last summer. -
Who's on first? Time for an IRB member roster
If your IRB office is well-organized, but IRB member information is dated and difficult to track, then it's time for a simple electronic solution: an IRB member roster. -
Compliance Corner: IRB effectively handles research concerns
Human subjects research organizations need a thorough, fair, and effective way of handling complaints and concerns about research trial ethical and regulatory violations. -
IOM: Cancer research needs new focus
Improved treatments for cancer will be delayed and patient lives will be lost unnecessarily unless the efficiency and effectiveness of the clinical trials system improves, a new report from the Institute of Medicine (IOM) concludes.